Varian, BrainLAB book 14 orders for Novalis Tx

Varian Medical Systems and BrainLAB have booked 14 orders for the Novalis Tx radiosurgical platform, which combines technologies from both companies to offer noninvasive treatment options for patients.

The orders for the Novalis Tx platform, launched in September 2007, include 10 in the United States and four in Europe, according to the companies.

The Palo Alto, Calif.-based Varian and the Munich, Germany-based BrainLAB said the Novalis Tx allows multiple beam energies from six to 20 million electron volts for treating deep-seated tumors, sparing surrounding healthy tissue.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.